Anti-Human TGFβRII Therapeutic Antibody (TR2B209)

Recombinant monoclonal antibody specifically binds to human TGF-β type II receptor to inhibit the signal transduction of human TGF-β signal into cells are produced by immunizing human antibody-producing transgenic mice generated by genetic engineering techniques with the soluble human TGF-β type II receptor.
Supplier Creative Biolabs
Product # TAB-651CT
Pricing Inquiry
Host Human
Target TGFβRII
Species Reactivity Rat, Human
Type Human antibody
Applications Used for immunoassay techniques such as: Enzyme-linked Immunosorbent Assay; Western Blot; Flow Cytometry; Inhibit
Feedback